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ng by ElsAbstract Objective: The purpose of this study is to investigate the anatomical and pathological
features of the gastrointestinal stromal tumors.
Patients and methods: in the period between 2008 and 2010 multislice CT images of 32 patients
affected by GIST were analyzed, the scanning was obtained before and after contrast medium injec-
tion also the bowel distension was obtained by the diluted gastrograﬁn. Images were evaluated for
presence, site and origin of the tumor as well as growth pattern relative to the bowel wall density,
relationship with adjacent structures and presence or absence of lymph nodes and metastases.
Results: Thirty two patients with gists were identiﬁed (17 men and 15 women; mean age,
55.6 years). The primary tumor was located in the stomach in 14 cases, in the small intestine in
10 cases, in the ceacum and rectum in 5 and 3 cases, respectively. Mean primary tumor size was
14.3 cm (range from 2 to 18 cm). Tumors were typically with regular margins (12/32 cases,
37.5%), lobular (4/32 cases, 12.5%) while (16/32 cases, 50%) were irregular. Central ﬂuid attenu-
ation was seen in (15/32 cases, 49%). An extramucosal origin was deﬁnitely established in (28/32
cases, 87%). In (10/32 cases, 31.25%), the lesions exhibited extraluminal growth. Inﬁltration of414163.
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2 S. Abdel-Monem et al.the adjacent structures was observed in (20/32 cases, 62.5%). Metastases were detected in (9 /32
cases, 28%) at presentation. Hepatic metastases were detected in four cases, in the omentum in three
cases and lymphadenomegaly in two cases. Intestinal obstruction were detected in three cases and
ascites in only one patient.
Conclusion: Multislice CT images can be considered an essential tool for the diagnosis and staging
of gists.
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Gastrointestinal stromal tumors are rare and the term GIST,
ﬁrst used by Mazur and Clark in 1983, encompasses a hetero-
geneous group of nonepithelial neoplasms composed of
spindle or epithelioid cells, which display a range of differenti-
ation. There has been considerable debate in the literature
regarding the nomenclature, origin, differentiation, and clini-
cal behavior of these tumors (1,2).
Benign tumors can be discovered incidentally at surgery
and are completely excised (3). The increasing use of computed
tomography (CT) and endoscopy of the upper gastrointestinal
tract is also a means for the detection of asymptomatic tumors.
GISTs can originate anywhere along the gastrointestinal tract
or beyond it in the mesentery or omentum (3,4). They typically
arise in the bowel wall, usually from or between the muscularis
propria and muscularis mucosa (4). Articles on the investiga-
tion of large series of GISTs have been published in the surgi-
cal and pathologic literature, but little emphasis has been
placed on the speciﬁc radiologic appearances of these tumors.
The purpose of this study is to investigate the anatomical and
pathological features of the gastrointestinal stromal tumors.
2. Patients and methods
We prospectively evaluated the CT images of 32 patients (17
men and 15 women, aged 40–77 years) in the period between
2008 and 2010 .The deﬁnitive diagnosis was provided by histo-
logical examination of the surgical specimen. In 18 patients CT
was needed to investigate its submucosal extension after endos-
copy due to upper gastrointestinal bleeding. Among them 12
patients had the bleeding associated with anemia and dyspep-
sia. In eight cases, CT was performed for nonspeciﬁc symp-
toms of fatigue and weight loss, while three patients had a
palpable abdominal mass. Finally, in three cases, GIST was
an incidental ﬁnding on CT (during CT-enhanced examination
performed for evaluation of the liver, showed no clinical symp-
toms related to the gastrointestinal tract).
3. Scanning protocol
CT scans were obtained by Asteion multidetector helical CT
scanner (Toshiba Medical Systems, Tokyo, Japan). Axial
images were obtained with 3.0-mm collimation, 16.5-mm table
feeding per rotation, and 0.75-s gantry rotation time using a
dual-phase protocol. The patients before the examination
had been fasting for at least 6 hours and drinking 750 ml of
water mixed with 40 ml gastrographin as an intraluminal con-
trast agent in order to obtain a dilation of the gastrointestinal
tract.After the initial standard scanning, a dose of 100 ml of
iodinated nonionic contrast material (Ultravist 300, Schering,
Guangzhou, China) was administered intravenously with an
autoinjector (Medrad Vistron) at the rate of 3.0 ml/s. Dual-
phase, contrast-enhanced scans were obtained at 30 and 60 s
after the start of the injection during the dominant arterial
and parenchymal phases, respectively. After acquisition and
reconstruction of all the native high-resolution data set,
MPVR was performed .Curved planar reformations and other
three-dimensional reconstruction images of the mass were
created.
The images were assessed for:
– Morphological changes to the intestinal wall caused by the
presence of a recognizable, expansile mass in the wall.
– -Portion of the gastrointestinal tract involved by the
tumor (stomach, duodenum, jejunum, ileum, colon and
rectum).
– Tumor size, origin and growth pattern relative to the
affected organ (deﬁned as intra- or extraluminal, depending
on whether more or less than half of the tumor lay inside or
outside the lumen).
– Attenuation, deﬁned as homogeneous or heterogeneous
according to enhancement characteristics.
– Margin morphology of both mucosal and extramural com-
ponents (regular if smooth or lobular; irregular if ﬁnely
jagged).
– Presence of mucosal ulcerations at the lesion site.
– Relationship with adjacent structures or organs; inﬁltration
was hypothesized in the absence of a clear cleavage plane.
– Presence of distant metastases.
– Evidence of lymph nodes; any node detected on the scans
was considered pathological, regardless of diameter.
– Presence of ancillary ﬁndings, such as intestinal occlusion
or ascites.4. Results
Table 1 shows personal data of the studied groups where
we have 32 patients (17 men and 15 women, aged 40–
77 years).
Table 2 shows the clinical presentation of the studied group
including GIT bleeding, anemia, weight loss, abdominal mass
and incidental ﬁnding.
All the tumors in this group were single tumors. Fourteen
cases originated from stomach (Figs. 1 and 2) in this order fun-
dus, pyloric canal and then the cardia in 7, 4 and 3 cases,
respectively. The disease involved the small intestine (Figs. 3
and 4) in ten cases and in the cecum (Figs. 5 and 6) and rectum
in 5 and 3 cases, respectively (Table 3).
Table 1 Sociodemographic data.
Gender (total n= 32) 17 males (54%) and 15 females (46%)
Age at investigation 40–77 (mean 55 ± 3.6)
Table 2 Clinical presentation at time of investigation.
Presentation Number of cases
Bleeding 18
Anemia (after bleeding) 12
Weight loss 8
Abdominal mass 3
Incidental 3
Figure 2 MSCT axial scan of the stomach shows GIST at the
pyloric region.
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(68.75%) were intraluminal while in ten cases (31.25%) were
extraluminal (Table 4).
Tumor diameter ranged from a minimum of 2 cm to a max-
imum of 18 cm (mean 14.3 cm). In detail, gastric lesions ranged
from 2 to 17 cm (mean 9.3 cm), intestinal lesions from 3 to
16 cm (mean 9.5 cm), and the mean rectal lesion was 7.5 cm
(Table 5).
In 28 cases (87.2%) GISTs were originated in muscularis
propria while in four cases (12.8%) GISTs originated in mus-
cularis mucosa (Table 6).
Extra-mucosal origin of the tumors had occurred in 28 of
32 cases and suggested by the presence of raised mucosa at
the lesion site.
Tumors were typically with regular margins (12/32 cases,
37.5%), lobular (4/32 cases, 12.5%) while (16/32 cases, 50%)
were irregular (Table 7).Figure 1 MSCT axial scan of the stomach shows GIST with
intraluminal growth.
Figure 3 MSCT axial scan of the small bowel shows GIST mass
(M) with internal vessel (V).Presence of mucosal ulcerations at the lesion site was de-
tected in (9/32 cases, 28%).
Inﬁltration of the adjacent structures was observed in
(20/32 cases, 62.5%) where there was absence of the cleavage
plane.
Figure 4 MSCT of the abdomen of the same case with sagittal
reconstruction shows extraluminal extension of the GIST.
Figure 5 MSCT scan of the cecum shows large GIST with
absence of the cleavage plane.
Figure 6 MSCT scan of the same case with coronal reconstruc-
tion shows inﬁltration of the mass to the surroundings with
absence of the cleavage plane.
Table 3 Tumor site.
Site Incidence
Gastric 14 (43.75%)
Small intestine 10 (31.25%)
Cecum 5 (15.6%)
Rectum 3 (9.4%)
Table 4 Growth pattern of the tumor.
Growth pattern Incidence
Intraluminal 22 (68.75%)
Extraluminal 10 (31.25%)
Table 5 Tumor diameter mean.
Site Diameter mean (cm)
Gastric 13.3
Small intestine 9.5
Cecum 9.5
Rectum 7.5
4 S. Abdel-Monem et al.The tumoral mass appeared on CT scans as homogeneous
hypoattenuated density in 8 and in 24 as heterogeneous den-
sity. Fifteen tumors showed central massive hypoattenuation
of ﬂuid density. After the intravenous injection of a contrast
agent, the tumors showed irregular heterogeneous enhance-
ment. In one patient, internal vessels were detected during
the arterial dominant phase.
At presentation, metastatic foci were detected in 9 patients;
4 in the liver, three cases and in the omentum (Fig. 7). The
hepatic metastases appeared as focal masses with (Fig. 8)
heterogeneous enhancement in the parenchymal stage. In the
patients with metastases to the omentum, CT scans revealed
an increase omental density. Lymphadenomegaly was ob-
served in two cases (Table 8).According to ancillary ﬁndings there were intestinal
obstruction in 3 cases and ascites in only one patient.
All tumors conﬁrmed by histopathological examination to
be GISTs after surgery.
Table 6 Tumor origin.
Origin Incidence
Muscularis propria 28 (87.2%)
Muscularis mucosa 4 (12.8%)
Table 7 Tumor margin.
Site Incidence
Regular 12 (37.5%)
Lobular 4 (12.5%)
Irregular 16 (50%)
Figure 7 MSCT axial scan of the upper abdomen shows GIST
mass at the small bowel with omental deposit.
Figure 8 MSCT axial scan of the upper abdomen shows GIST
mass at the stomach with 2 small liver metastases.
Table 8 Distribution of the metastases.
Site Number of cases
Liver 4
Omentum 3
Lymph nodes 2
Bone 0
Lung 0
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The term gastrointestinal stromal tumor (GIST) has tradition-
ally been used as a descriptive term for soft-tissue tumors of
the gastrointestinal tract. Although their exact incidence is still
somewhat unclear, it is now estimated that between 5 000
and10 000 people each year develop GISTs in the world;
men and women are equally affected (5). GISTs were previ-
ously thought to be smooth muscle neoplasms, and most were
classiﬁed as leiomyosarcoma. With the advent of immunohis-
tochemistry and electron microscopy, it has become apparent
that GIST may have myogenic features (smooth muscle
GIST), neural attributes (gastrointestinal autonomic nerve tu-
mor), characteristics of both muscle and nerve (mixed GIST)
or may lack differentiation (GIST not otherwise speciﬁed)
(6). GISTs are often discovered incidentally at surgery and
should be completely excised. The increasing use of computedtomography (CT) and endoscopy of the upper gastrointestinal
tract is a non-or minimally invasive means for the detection of
asymptomatic GISTs (7).
Imaging examination plays an important role in preopera-
tive diagnosis and postoperative evaluation for GIST (8).
Multslice spiral CT is valuable in the diagnosis of malignant
GIST (9).
In the present study, the mean age at presentation was over
50 years, as that in other series (10,11). Male predominance is
a feature in most previous studies (12,13) but is usually less
marked than the nearly in our study.
GISTs can arise from the wall of any portion of the gastro-
intestinal tract, from the esophagus to the anus (14) and repre-
sent the most common type of mesenchymal tumor, if we
exclude the esophagus, 25% are GISTs and 75% are leiomyo-
mas (14,15). The GIST locations found in our study (stomach
43.75%, small intestine 31.25%, cecum 15.6% and rectum
9.3% reﬂect the data reported in the literature (16,17).
Tumor size varies from millimeters which generally an inci-
dentally discovered to 30 cm or more (18,19). In the present
study, tumor diameter ranged from a minimum 2 cm to a max-
imum of 18 cm (mean 14.3 cm). In detail, gastric lesions ranged
from 2 to 17 cm (mean 9.3 cm), intestinal lesions from 3 to
16 cm (mean 9.5 cm), and the mean rectal lesion was 7.5 cm.
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nate in muscularis propria (outer wall layers) while those aris-
ing in the muscularis mucosae (deeper wall layers) are rare and
more frequently involve the colon (2). In our study, in 28 cases
(87.2%) GISTs were originated in muscularis propria while in
four cases (12.8%) GISTs originated in muscularis mucosa.
The stomach and small bowel consistently account for the
vast majority of cases of GIST, usually with a division that fa-
vors the stomach (20,21). Multiplicity of primary tumors is
rare (21,22). However, tumors arising outside the bowel wall
constitute up 10% of cases (23). In the present study the most
common site of primary tumors as we had found in the stom-
ach versus other studies where the small bowel rather than the
stomach was the most common primary site (20,21). A possi-
ble explanation for the other ﬁnding could be the misclassiﬁ-
cation of a number of mesenteric and omental tumors as
being of small-bowel origin, a theory supported by the large
proportion of extraluminal tumors.
Regarding to tumor behavior tumors of small-bowel origin
tend to have more aggressive behavior and thus a worse prog-
nosis than that of tumors originating in other gastrointestinal
sites (22,23) this agree our results where the presentation of
most small bowel tumors associated with metastasis either to
the omentum or the liver.
Regarding the most common symptoms of these tumors
still there is wide discrepancy about it, we had most commonly
gastrointestinal bleeding in 56.25% or signs and symptoms of
anemia caused by occult bleeding. In other reports, the most
common symptom was abdominal pain (23,24).
Features at clinical presentation are dependent on tumor
size. Small tumors are usually an incidental surgical ﬁnding
(24), as we had in three cases, while large tumors are usually
symptomatic including gastrointestinal hemorrhage, often
with an acute episode, abdominal pain, a mass, weight loss,
nausea, and vomiting (24). Many GISTs are incidentally found
during a periodic medical check-up. Tumors found inciden-
tally, which have a better prognosis, have a mean diameter
of 2.5 cm (25).
We had three cases (9.3%) with intestinal obstruction at
presentation, other series revealed small bowel obstruction re-
ported in up to 30% (26) but accounts for less than 10% of
presentations in most reports (27,28) and other ﬁndings, which
also show such obstructions to be rare, even in advanced met-
astatic disease (29,30).
The rarity of ascites suggests that these tumors do not incite
a local inﬂammatory reaction. The occurrence of ascites at fol-
low-up is likely, due at least in part to treatment (31). In our
study we reported only one case with ascites.
Endoluminal tumors will result in symptoms sooner, with a
greater expectation for curative surgery (31). Our referral pat-
tern also accounts for the high rate of metastases at presenta-
tion, however, the incidence of metastases at presentation in
the largest clinical series (3) of malignant GISTs approached
50%.
The development of local recurrence and metastases at
follow-up is a feature of this disease. The distribution of
metastases is predictable, with the liver and peritoneum
dominating (3,16). The liver is the most common metastatic
site at both presentation and disease relapse (3). Metastases
to bone and the lung have been previously described, but
they are distinctly uncommon, as was the case in our pa-
tients (3,19).The incidence of lymph node metastases is more controver-
sial. We found two cases of enlarged lymph nodes according to
CT criteria. A number of other investigators (13,32) have not
reported metastatic disease to the lymph nodes. However,
pathologic reports indicate lymph node metastases can occur
but with insufﬁcient frequency to warrant routine lymphade-
nectomy (3).
Some authors believed that the tumor behaviors were more
malignant behavior in the small intestinal tumor than that of
the gastric tumor (14,19). However, in our series, no signiﬁcant
correlation existed between lesion location and malignancy.
This may be due to the small sample size in our series.
The liver is the most common metastatic site then the
omentum in our series and that concurs with many reports
(33–35).
Some of the peritoneal deposits in our series may have been
mesenteric nodal metastases. There is agreement that complete
surgical excision of the primary tumor offers the best chance of
cure (3,13,21). In the absence of metastatic disease, complete
resection is usually achievable, since the tumor is typically lim-
ited by the serosa of the organ, and when invasive, does so
with a pushing rather than inﬁltrative border, allowing en bloc
resection with clear margins (18,20).
The diagnosis of malignant GIST can be suggested on CT
scans with the presence of a large well-circumscribed tumor
arising from the stomach or small bowel that is usually pre-
dominantly extraluminal and has a heterogeneously enhancing
soft-tissue rim surrounding a necrotic center. Metastases, if
present, will be to the liver or peritoneum. Lymph node
enlargement is not a feature.
In conclusion, despite overlap of the radiologic appearances
of GISTs and other sarcomatous tumors, the authors believe
that if the above imaging features and/or tumor behaviors
are recognized, there should be a high level of suspicion for
GIST.
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